Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Diltiazem Plus Fusidic Acid for Episiotomy Healing
NCT07545187Phase 2Completed
- Start
- Jun 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DOLIZEM in surgical site infection (SSI). Started Jun 2025; status: completed.
02
Drugs
DOLIZEM
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07545187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07545187.